CURTEL M
TM Tablets combine Telmisartan and Metoprolol Succinate to provide comprehensive management of hypertension and associated cardiac conditions. Telmisartan, an angiotensin II receptor blocker (ARB), helps relax blood vessels and lower blood pressure, while Metoprolol Succinate, a beta-blocker, reduces heart rate and myocardial workload. This dual mechanism provides better cardiovascular protection and is commonly used in patients with hypertension, angina, and other heart-related conditions.
Composition
- Telmisartan 40 mg
- Metoprolol Succinate 50 mg
Key Features & Benefits
- Dual-Action Therapy: Combines ARB and beta-blocker
- Effective BP Control: Provides sustained reduction in blood pressure
- Heart Rate Control: Metoprolol helps reduce cardiac workload
- Cardioprotective: Reduces risk of cardiovascular events
- Improved Compliance: Single-pill combination therapy
Recommended Usage
- To be taken as prescribed by a healthcare professional
- Preferably taken at the same time each day
- Do not abruptly discontinue beta-blocker therapy
Safety Information
- Not recommended in patients with hypersensitivity to any component
- Use cautiously in patients with asthma, diabetes, or heart block
- Monitor blood pressure and heart rate regularly
- Do not discontinue therapy without medical advice
Storage Instructions
- Store in a cool, dry place
- Protect from moisture and direct sunlight
- Keep out of reach of children
